|
The recent virtual workshop
on “Safety of GH treatment in cancer survivors” successfully held in 2021 with over 50 participants. A review paper concerning this meeting was published prior to the meeting (Pituitary. 2021 Oct;24(5):810-827). The outcome of the workshop resulted in a manuscript that has been published:
Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement.
Eur J Endocrinol. 2022 Apr 21;186(6):35-52. doi: 10.1530/EJE-21-1186.
2022 Online.
Potential Up-coming Workshop Topics:
Update on diagnosis of GHD
Genetics of short stature
Transition of GHD patients
Suggestions are welcome!
|
